PARP1 and posterior cortical atrophy: In addition, it is necessary to investigate whether the efficacy of PARP inhibitors can be enhanced or possible resistance problems overcome by modulating the expression or function of KANK3.Through these in-depth studies, it is expected to provide a stronger theoretical basis and more innovative treatment strategies for the precise treatment of PCa.